The Distinctive Features behind the Aggressiveness of Oral and Cutaneous Squamous Cell Carcinomas

被引:5
|
作者
Alonso-Juarranz, Miguel [1 ,2 ]
Mascaraque, Marta [3 ,4 ]
Carrasco, Elisa [3 ,5 ]
Gracia-Cazana, Tamara [6 ]
De La Sen, Oscar [1 ,2 ]
Gilaberte, Yolanda [6 ]
Gonzalez, Salvador [5 ,7 ]
Juarranz, Angeles [3 ,5 ]
Falahat, Farzin [1 ,2 ]
机构
[1] Hosp Clin San Carlos, Oral & Maxillofacial Surg Serv, Madrid 28040, Spain
[2] Univ Complutense, Fac Med, Surg Dept, Madrid 28040, Spain
[3] Univ Autonoma Madrid, Dept Biol, Madrid 28049, Spain
[4] Miguel Servet Univ Hosp, Translat Res Unit, Inst Invest Sanitaria Aragon IIS, Zaragoza 50009, Spain
[5] Inst Ramon y Cajal Invest Sanitaria IRYCIS, Dept Expt Dermatol & Skin Biol, Madrid 28034, Spain
[6] Miguel Servet Univ Hosp, Dept Dermatol, Inst Invest Sanitaria Aragon IIS, Zaragoza 50009, Spain
[7] Univ Alcala, Dept Med & Med Specialties, Madrid 28871, Spain
关键词
oral squamous cell carcinoma; cutaneous squamous cell carcinoma; tumor microenvironment; cancer-associated fibroblasts; immune cells; tertiary lymphoid structures; EPITHELIAL-MESENCHYMAL TRANSITION; GENOMIC CHARACTERIZATION; FIBROBLAST ACTIVATION; CANCER; HEAD; RISK; PROGRESSION; INVASION; THERAPY; MACROPHAGES;
D O I
10.3390/cancers15123227
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary In this review, we describe the recent studies that define the genetic alterations and composition of the stroma of oral and cutaneous squamous cell carcinomas (OSCC and CSCC, respectively). Mutations in tumor suppressor genes and protooncogenes cooperate in determining the differentiation, aggressiveness, and metastatic potential of these types of cancers. Driver mutations in tumor suppressor genes are more frequently observed in OSCC than CSCC. We also describe the differential composition of the tumor microenvironment and how this influences the aggressiveness of each tumor type. Although both OSCC and CSCC tumors are highly infiltrated by immune cells, high levels of tumor-infiltrating lymphocytes have been more frequently reported as predictors of good responses in OSCC than CSCC. Squamous cell carcinomas arise from stratified squamous epithelia. Here, a comparative analysis based on recent studies defining the genetic alterations and composition of the stroma of oral and cutaneous squamous cell carcinomas (OSCC and CSCC, respectively) was performed. Both carcinomas share some but not all histological and genetic features. This review was focused on how mutations in tumor suppressor genes and protooncogenes cooperate to determine the differentiation, aggressiveness, and metastatic potential of OSCC and CSCC. In fact, driver mutations in tumor suppressor genes are more frequently observed in OSCC than CSCC. These include mutations in TP53 (encoding pP53 protein), CDKN2A (encoding cyclin dependent kinase inhibitor 2A), FAT1 (encoding FAT atypical cadherin 1), and KMT2D (encoding lysine methyltransferase 2D), with the exception of NOTCH (encoding Notch receptor 1), whose mutation frequency is lower in OSCC compared to CSCC. Finally, we describe the differential composition of the tumor microenvironment and how this influences the aggressiveness of each tumor type. Although both OSCC and CSCC tumors are highly infiltrated by immune cells, high levels of tumor-infiltrating lymphocytes (TILs) have been more frequently reported as predictors of better outcomes in OSCC than CSCC. In conclusion, OSCC and CSCC partially share genetic alterations and possess different causal factors triggering their development. The tumor microenvironment plays a key role determining the outcome of the disease.
引用
收藏
页数:17
相关论文
共 50 条
  • [42] Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas
    Pelster, Michael W.
    Wayne, Jeffrey D.
    Yoo, Simon
    JAMA ONCOLOGY, 2016, 2 (01) : 130 - +
  • [43] Clinical features, treatment, and outcomes of cutaneous and oral squamous cell carcinoma in avian species
    Zehnder, Ashley M.
    Swift, Laura A.
    Sundaram, Ash
    Speer, Brian L.
    Olsen, Geoff P.
    Hawkins, Michelle G.
    Paul-Murphy, Joanne
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2018, 252 (03): : 309 - 315
  • [44] Tumour Budding Correlates with Aggressiveness of Cutaneous Squamous-cell Carcinoma
    Karayannopoulou, Georgia
    Euvrard, Sylvie
    Kanitakis, Jean
    ANTICANCER RESEARCH, 2016, 36 (09) : 4781 - 4785
  • [45] To assess the aggressiveness of oral squamous cell carcinoma in the young population
    Shaikh, Shafqat Ali
    Abbas, Syed Akbar
    Haq, Muhammad Ehteram Ul
    Ayub, Bushra
    Qureshi, Talha Ahmed
    Khalil, Amna
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2022, 72 (10) : 1937 - 1941
  • [46] Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients
    Smith, KJ
    Hamza, S
    Skelton, H
    DERMATOLOGIC SURGERY, 2004, 30 (04) : 634 - 641
  • [47] Enhanced Expression of Podoplanin in Oral Carcinomas in situ and Squamous Cell Carcinomas
    Funayama, Akinori
    Cheng, Jun
    Maruyama, Satoshi
    Yamazaki, Manabu
    Kobayashi, Takanori
    Syafriadi, Mei
    Kundu, Sukalyan
    Shingaki, Susumu
    Saito, Chikara
    Saku, Takashi
    PATHOBIOLOGY, 2011, 78 (03) : 171 - 180
  • [48] Toll-like receptors-4 and-5 in oral and cutaneous squamous cell carcinomas
    Omar, Abdirisak Ahmed Haji
    Korvala, Johanna
    Haglund, Caj
    Virolainen, Susanna
    Hayry, Valtteri
    Atula, Timo
    Kontio, Risto
    Rihtniemi, Jarmo
    Pihakari, Antti
    Sorsa, Timo
    Hagstrom, Jaana
    Salo, Tuula
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2015, 44 (04) : 258 - 265
  • [49] Small and Thin Oral Squamous Cell Carcinomas may Exhibit Adverse Pathologic Prognostic Features
    Mohammed Nur, Mutaz
    Al Saadi, Maimuna
    O'Regan, Esther M.
    Van Harten, Maria
    Toner, Mary
    HEAD & NECK PATHOLOGY, 2021, 15 (02): : 461 - 468
  • [50] Small and Thin Oral Squamous Cell Carcinomas may Exhibit Adverse Pathologic Prognostic Features
    Mutaz Mohammed Nur
    Maimuna Al Saadi
    Esther M. O’Regan
    Maria Van Harten
    Mary Toner
    Head and Neck Pathology, 2021, 15 : 461 - 468